Medullary Thyroid Cancer News and Research

Ectopic thyroid cancer is rare, but not beyond the realm of possibility
10/05/2011 - In infrequent cases, clumps of thyroid cells can develop from birth in bodily sites other than the gland itself. Called ectopic thyroid, this tissue is subject to cancer just like any other organ, leading in rare instances to ectopic thyroid cancer (ETC).
Too little blood-borne adiponectin may boost risk of thyroid cancer
10/03/2011 - Research conducted by a team of Greek and American endocrinologists has revealed that too little of the metabolic protein adiponectin in the blood may increase the likelihood of thyroid cancer, while higher levels may entail a lower-than-average risk of the disease.
Study analyzes metastases of medullary thyroid cancer
06/20/2011 - Public health authorities are aware of the most common sites of medullary thyroid cancer (MTC) metastases, but a new study from France's Institut Gustave Roussy and the University Hospital in Tours has tabulated the prevalence of the more unusual sites to which the disease can spread.
Study of thyroid cancer in Italy points to better surveillance, not higher incidence
06/01/2011 - A survey of 15 years' worth of data mined from Italy's cancer registries has found that though diagnoses of the disease have increased over time, this surge appears to be due mainly to improvements in medical surveillance and tumor detection.
Scientists explore how thyroid cancer metastasizes, often staying dormant for years
05/23/2011 - Distant metastases of thyroid cancer can dramatically reduce a patient's likelihood of survival, which is one reason why a scientist at the Ohio State University College of Medicine recently reviewed the current clinical understanding of how thyroid carcinoma cells migrate.
Studies summarize promising innovations in molecular diagnosis of thyroid cancer
05/18/2011 - Two recently released studies, one written by a pair of Greek endocrinologists and the other by an American pathologist, summarize the latest advancements made into the molecular analysis and diagnosis of thyroid cancer.
Study examines occult medullary thyroid cancer
05/11/2011 - Medullary thyroid cancer (MTC) is a relatively rare form of thyroid disease, one that is often difficult to detect, which is one reason why scientists at the Johns Hopkins University School of Medicine recently attempted to quantify the rate at which MTC goes undiscovered until a thyroidectomy.
Genetic analysis spots hereditary cases of medullary thyroid cancer
04/21/2011 - A significant percentage of medullary thyroid cancer (MTC) cases are hereditary, caused by a genetic mutation that researchers recently sought while examining the DNA of Middle Eastern adults with apparently sporadic cases of the disease.
Study establishes epidemiology of thyroid cancer by type, demographic group
04/19/2011 - Researchers from the National Cancer Institute (NCI) and several U.S. universities recently analyzed state-based thyroid cancer data in order to determine the incidence of each variety of the disease among American demographic groups.
Medullary thyroid cancer may literally be 'a pain in the neck'
04/18/2011 - It can be difficult to detect the presence of medullary thyroid cancer (MTC), but new research suggests that individuals with neck pain are more likely than those without it to have an advanced case of the disease.
FDA approves drug to treat aggressive medullary thyroid cancer
04/11/2011 - After an international, double-blind clinical trial conducted among patients with advanced medullary thyroid cancer, the U.S. Food and Drug Administration (FDA) recently approved a medication called vandetanib to treat the disease.
Survey of medical literature attempts to zero in on medullary thyroid cancer rate
02/11/2011 - Researchers at the Ohio State University Medical Center recently published a review of 40 years' worth of autopsies in an effort to more accurately determine the rate of medullary thyroid cancer in the U.S.
Scans show effectiveness of medullary thyroid cancer treatment, experts say
02/03/2011 - Researchers have reported using positron emission tomography (PET) scans to determine the effectiveness of a new prescription treatment for medullary thyroid cancer.
Research team says diagnostic test for medullary thyroid cancer has mixed results
02/01/2011 - A pair of Italian clinicians recently determined that serum calcitonin measurement may not always be a reliable indicator of the presence of medullary thyroid cancer.
Researchers find that vandetanib may be an effective treatment for medullary thyroid cancer patients
09/30/2010 - A recent phase three trial conducted by the National Cancer Institute (NCI) suggests that vandetanib, a once-daily selective oral inhibitor of vascular endothelial growth - which describes the lining of cells, extended progression-free survival (PFS) in patients with medullary thyroid cancer, Endocrine Today reports.
Relay for Life co-chair Jeff Vereecke battling rare form of thyroid cancer
08/16/2010 - Although thyroid cancer has a lower fatality rate than other tumors, there has been a 2.4-fold increase in its occurrence over the past 27 years. The Centers for Disease Control (CDC) reports that this form of cancer is more prevalent in women than men; however, men are still at risk.
 
SHOW MAIN MENU
SHOW SUB MENU